NewsRoom Articles - Page 111 of 224

TuesdaySep 06, 2022 11:22 am

Research Indicates Better Sleep Efficiency Benefits Fibromyalgia Sufferers

New research has found that improved sleep efficiency in patients who suffer from fibromyalgia and insomnia may improve their pain-related disorder. Fibromyalgia is a condition characterized by extensive musculoskeletal pain and tenderness, which is often accompanied by fatigue, mood and memory as well as sleep issues. The disorder is often caused by stressful events, which may include emotional, psychological or physical stress. Injuries or viral infections may also cause this pain disorder. On the other hand, insomnia is a sleep disorder that makes it hard for individuals to fall asleep or stay asleep. This common disorder may also cause individuals…

FridaySep 02, 2022 10:09 am

Study Highlights Need for Postnatal Depression Screening

Researchers at the University of Queensland have highlighted the need to screen for perinatal depression for women during the pregnancy period, after learning that women suffering from persistent depression have a heightened risk of developing the condition. Perinatal depression includes symptoms of depression, stress and anxiety that women sometimes experience from conception to a year following infant birth. The study’s objective was to assess the prevalence, timing of onset and duration of depression symptoms in the perinatal period in women with depression. The study involved more than 7,000 participants who were divided into two subgroups: women who had previously been…

ThursdaySep 01, 2022 10:58 am

Research Suggests Some 50% of Cancers Result from Preventable Factors

Cancer is said to be the second-leading cause of death globally, following heart disease. Among the different types of cancer, lung cancer is the leading cause of cancer death, followed by colorectal and liver cancers. A new study suggests that roughly 44% of the deaths caused by cancer can be attributed to risk factors that are preventable. These factors include drinking too much alcohol, smoking and having a high BMI. The researchers were focused on analyzing the relationship between cancer and various risk factors, using data obtained from the Global Burden of Disease project by the Institute for Health Metrics…

ThursdaySep 01, 2022 9:00 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP), Moving the Needle in GBM and Brain Cancer Research

When CNS went public in 2019, the funds went primarily into pre-clinical preparation, trial design approval, and drug manufacturing for its potentially pivotal global clinical trial of Berubicin for recurrent glioblastoma multiforme (“GBM”) So far, CNS has received FDA Fast Track Designation on its Berubicin clinical study, inching the company closer to offering a viable solution to the millions of people dealing with GBM, a devastating malignant brain cancer It remains committed to pushing the envelope in terms of research and development of potential GBM treatment, as we ll as brain cancers in general, to offer a viable solution to…

WednesdayAug 31, 2022 12:47 pm

Ways to Prevent a Child from Choking

Children are prone to various accidents that can occur anywhere and at any time. Among the most common of these accidents is choking, which occurs when a child’s airway is obstructed. Unlike an adult’s airway, a child’s airway is smaller, which means it can easily be blocked. Figures show that an estimated 40 children are admitted to emergency rooms for choking, with one child losing their life by choking on food every five days in America. Below, we look at various choking hazards you should be aware of and what foods you can avoid as well as how to prevent…

WednesdayAug 31, 2022 11:30 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Pioneering Efforts as Studies, Research Show Psilocybin’s Potential in Treating AUD

A new study shows promise in treating alcohol addiction with psychedelic mushroom compound, psilocybin These results align with efforts and expectations of Cybin, a leading ethical biopharmaceutical company championing psilocybin After receiving FDA approval, the company is moving forward with a first-in-human clinical trial evaluating CYB003 A new study published in JAMA Psychiatry offers hope for those struggling with alcoholism (https://ibn.fm/jV5o9), showing promise in treating alcohol addiction with the psychedelic compound psilocybin. This news aligns with initiatives of Cybin (NEO: CYBN) (NYSE American: CYBN), a leading ethical biopharmaceutical company, which has a drug in development, CYB003, for the treatment of alcohol…

TuesdayAug 30, 2022 11:44 am

Study Finds Children Have Better Outcomes with Kidney Transplants from Living Donors

A new study has found that pediatric patients who undergo kidney transplants may have better outcomes if the donated kidney comes from a biologically unrelated and living donor in comparison to a deceased donor. For their research, the scientists reviewed data obtained from the Organ Procurement and Transplantation Network database during the period between January 2001 and September 2021. The investigators examined more than 12,000 children who had received kidney transplants during the study period. Of the total number of children, 61% received kidneys from deceased donors, 36% received kidneys from living related donors and less than 3% received kidneys…

TuesdayAug 30, 2022 9:00 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Looking to Fill Glioblastoma Multiforme Treatment Gap with Berubicin Drug Product

CNS Pharmaceuticals is currently undertaking a potentially pivotal global study evaluating the efficacy and safety of Berubicin compared with Lomustine administered after first-line therapy for the treatment of recurrent glioblastoma multiforme (“GBM”) GBM is an aggressive form of cancer that occurs in the brain or spinal cord In the U.S., it affects between 12,000-15,000 new patients annually with a median survival rate of only 14.6 months from its diagnosis CNS’s drug development program is targeting the GBM drug market which is expected to expand at a CAGR of more than 4% between 2020 and 2030 On July 24, 2021, pre-clinical…

MondayAug 29, 2022 11:48 am

Study Looks into Why Deadly Brain Tumors Continue to Grow After Treatment

Gliomas are rare and fatal brain tumors that form when glial cells in the body grow uncontrollably. Glial cells usually support nerves in the body by helping an individual’s central nervous system function. These deadly tumors typically grow in the brain but may, in some cases, also grow in the spinal cord. New research has discovered that gliomas adapt to their surrounding brain environment in response to cancer treatment, developing interactions with nearby immune cells and neurons that prevent tumor cells from being identified easily by the body’s immune system. The study was conducted by an international team of experts,…

FridayAug 26, 2022 11:46 am

Study Explains How Threatening Cues Are Refined into Fear Signals

The fight-or-flight response is synonymous with most life forms. In moments of acute stress, your sympathetic nervous system will activate a sudden release of hormones that trigger a single response: fight or flight. Fear plays a major role in activating this response because it is usually activated in dire moments when a quick decision could be the difference between life and death. Scientists from the Salk Institute who were researching how the brain gathers threatening cues and distills them into fear signals have found a molecular pathway that plays a major role in creating the fear response. This pathway distills…